Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.55 |
| ▸ | CES1 | P23141 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.50 |
| ▸ | CES2 | O00748 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | GSK3B | P49841 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8746802 | 0.90 | TDP1 (0.58) | TDP1CES1CA1CA2SRD5A2 | |
| SCHEMBL14638882 | 0.78 | MAPK1 (0.50) | TDP1CES1CA1CA2SRD5A2 | |
| SCHEMBL1924807 | 0.77 | CES1 (0.73) | TDP1CES1CA1CA2SRD5A2 | |
| SCHEMBL10585970 | 0.74 | CES1 (0.57) | TDP1CES1CA1CA2SRD5A2 | |
| SCHEMBL21273296 | 0.74 | KMT2A (0.50) | TDP1CES1CA1CA2MAPK1 | |
| SCHEMBL10784508 | 0.72 | CES1 (0.62) | TDP1CES1CA1CA2SRD5A2 | |
| SCHEMBL15180824 | 0.72 | CES1 (0.79) | TDP1CES1CA1CA2SRD5A2 | |
| SCHEMBL4949082 | 0.72 | TDP1 (0.69) | TDP1CES1CA1CA2SRD5A2 | |
| SCHEMBL2099160 | 0.72 | CES1 (0.79) | TDP1CES1CA1CA2SRD5A2 | |
| SCHEMBL4944977 | 0.72 | TDP1 (0.69) | TDP1CES1CA1CA2SRD5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1534734-B1 | METHOD FOR THE SYNTHESIS AND SELECTIVE BIOCATALYTIC MODIFICATION OF PEPTIDES, PEPTIDE MIMETICS AND PROTEINS | ROCHE DIAGNOSTICS GMBH (DE) | 2008-05-07 | — | — | EP | claimed |
| US-20060149035-A1 | Method for the synthesis and selective biocatalytic modification of peptides, peptide mimetics and proteins | ROCHE DIAGNOSTICS GMBH (DE) | 2006-07-06 | — | — | US | claimed |
| EP-1534734-A1 | METHOD FOR THE SYNTHESIS AND SELECTIVE BIOCATALYTIC MODIFICATION OF PEPTIDES, PEPTIDE MIMETICS AND PROTEINS | BOEHRINGER MANNHEIM GMBH (DE) | 2005-06-01 | — | — | EP | claimed |
| WO-2004024751-A1 | METHOD FOR THE SYNTHESIS AND SELECTIVE BIOCATALYTIC MODIFICATION OF PEPTIDES, PEPTIDE MIMETICS AND PROTEINS | F. HOFFMANN-LA ROCHE AG (CH) | 2004-03-25 | — | — | WO | claimed |
| CN-116063505-B | Anti-GAL 3 antibodies and uses thereof | 真和制药有限公司 | 2024-05-03 | — | — | CN | disclosed |
| CN-117916269-A | Method for preventing aggregation of proteins | 真和制药有限公司 | 2024-04-19 | — | — | CN | disclosed |
| CN-115697418-A | Compositions and methods for treating muscular dystrophy | 艾维迪提生物科学公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-115666589-A | Compositions and methods for treating facioscapulohumeral muscular dystrophy | 艾维迪提生物科学公司 | 2023-01-31 | — | — | CN | disclosed |
| CN-115175704-A | Interleukin 10 conjugates and uses thereof | 新索思股份有限公司 | 2022-10-11 | — | — | CN | disclosed |
| CN-114375296-A | Nucleic acid polypeptide compositions and uses thereof | 艾维迪提生物科学公司 | 2022-04-19 | — | — | CN | disclosed |
| CN-113660946-A | IL-2 conjugates and methods of use thereof | 新索思股份有限公司 | 2021-11-16 | — | — | CN | disclosed |
| CN-113260374-A | Interleukin 10 conjugates and uses thereof | 新索思股份有限公司 | 2021-08-13 | — | — | CN | disclosed |
| WO-2008055118-A2 | METHODS AND SYSTEMS FOR IMMOBILIZING CORNEAL PROSTHESES | SHIUEY YICHIEH (US) | 2008-05-08 | — | — | WO | disclosed |
| EP-1763537-A2 | PEPTIDES FOR INHIBITING THE INTERACTION OF PROTEIN KINASE A AND PROTEIN KINASE A ANCHOR PROTEINS | Forschungsverbund Berlin e.V. (DE) | 2007-03-21 | — | — | EP | disclosed |
| WO-2006000213-A9 | PEPTIDES FOR INHIBITING THE INTERACTION OF PROTEIN KINASE A AND PROTEIN KINASE A ANCHOR PROTEINS | FORSCHUNGSVERBUND BERLIN EV (DE) | 2007-03-08 | — | — | WO | disclosed |
| US-20060149035-A1 | Method for the synthesis and selective biocatalytic modification of peptides, peptide mimetics and proteins | ROCHE DIAGNOSTICS GMBH (DE) | 2006-07-06 | — | — | US | disclosed |
| EP-1660523-A2 | INDUCTION OF ANTIVIRAL NEUTRALIZING ANTIBODIES IN HUMANS AND ANIMALS | BRD, vertreten durch das BM für Gesundheit und Soziale Sicherung, Letztvertreten durch den Präsidenten des Robert-Koch-Inst. (DE) | 2006-05-31 | — | — | EP | disclosed |
| WO-2006000213-A2 | PEPTIDES FOR INHIBITING THE INTERACTION OF PROTEIN KINASE A AND PROTEIN KINASE A ANCHOR PROTEINS | FORSCHUNGSVERBUND BERLIN E.V. (DE) | 2006-01-05 | — | — | WO | disclosed |
| WO-2005021574-A2 | INDUCTION OF ANTIVIRAL NEUTRALIZING ANTIBODIES IN HUMANS AND ANIMALS | BRD, VERTRETEN DURCH DAS BUNDESMINISTERIUM FÜR GESUNDHEIT UND SOZIALE SICHERUNG, LETZTVERTRETEN DURCH DEN PRÄSIDENTEN DES ROBERT-KOCH-INSTITUTES (DE) | 2005-03-10 | — | — | WO | disclosed |
| US-6783539-B1 | Phototriggerable, collagen-crosslinking compounds for wound closure | UNIVERSITY OF KANSAS MEDICAL CENTER | 2004-08-31 | — | — | US | disclosed |